^
Association details:
Biomarker:CD24 expression
Cancer:Triple Negative Breast Cancer
Drug:JQ-1 (BET inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Source:
Title:

IDENTIFICATION OF A STEMNESS-RELATED GENE PANEL ASSOCIATED WITH BET INHIBITION IN TRIPLE NEGATIVE BREAST CANCER

Published date:
09/30/2019
Excerpt:
Four of the identified stemness genes, GJA1, CD24, EPCAM, and SOX9, were found to be associated with worse patient outcome in TNBC.